RAPTOR PHARMACEUTICAL CORP Inactive Instrument
Company Raptor Pharmaceutical Corp
Equities
US75382F1066
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Paul Hoelscher
DFI | Director of Finance/CFO | 59 | 25/16/25 |
Kim Lee
IRC | Investor Relations Contact | - | 23/14/23 |
| Corporate Officer/Principal | 62 | - | |
David Happel
PRN | Corporate Officer/Principal | 62 | 23/14/23 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gregg Lapointe
CHM | Chairman | 65 | 01/15/01 |
Timothy Walbert
BRD | Director/Board Member | 57 | 11/11/11 |
Paul Hoelscher
DFI | Director of Finance/CFO | 59 | 25/16/25 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 85,306,787 | 79,995,700 ( 93.77 %) | 0 | 93.77 % |
Company contact information
Horizon Pharmaceutical LLC
7 Hamilton Landing Suite 100
94949, Novato
+
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +8.96% | 105B | |
| -1.43% | 104B | |
| +4.40% | 22.94B | |
| -12.15% | 22.34B | |
| -4.36% | 19.25B | |
| -39.98% | 17.08B | |
| -10.04% | 16.96B | |
| +38.61% | 12.63B | |
| +313.59% | 8.49B |
- Stock Market
- Equities
- Stock
- Company Raptor Pharmaceutical Corp